Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-25 @ 1:34 AM
NCT ID: NCT05231694
Eligibility Criteria: Inclusion Criteria: * people with first-ever ischemic stroke confirmed by CT or/and MRI; * 14 days to 6 months after stroke onset; * 50 years≤aged≤80 years; * 3≤modified Rankin Score (mRS)≤4, and Mini-Mental State Examinations (MMSE)\<27; * Patients can accept treatment with EA and have good compliance; * Patients have clear consciousness, pain perception and resolution ability to complete basic communication; * willing to participate and be randomized to one of the groups. Exclusion Criteria: * transient ischemic attack, subarachnoid hemorrhage, cerebral hemorrhage and other cerebrovascular diseases; * severe heart, liver, kidney dysfunction and severe coagulation dysfunction; * cerebral infarction caused by repeated recurrence of stroke, brain surgery or trauma, and brain tumors; * severe neurological deficits before stroke, such as visual and auditory impairment, aphasia, agnosia, severe hemiplegia, or affected limb function before stroke, such as cerebral palsy, polio, fracture, and mRs≥1; * diseases with affecting cognitive function such as congenital dementia, or alcohol, drug or substance abuse; * lactation, pregnancy or intend to be pregnant within 6 months; * needlesickness, needle phobia and skin infection at acupuncture site; * pacemaker, implantable cardioverter defibrillator carriers or conductive metallic foreign bodies in the body; * allergy to NGF; * currently enrolled in another clinical trial or participation in other clinical trials within the last 3 months.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 50 Years
Maximum Age: 80 Years
Study: NCT05231694
Study Brief:
Protocol Section: NCT05231694